Release Date: February 8, 1999 This content is archived.
BUFFALO, N.Y. -- Important advances in the diagnosis and treatment of respiratory diseases will be the focus of a symposium to be held from 8:45 a.m. to 5:30 p.m. Feb. 24 and from 8 a.m. to 12:45 p.m. Feb. 25 in the University Inn & Conference Center, 2401 North Forest Road, Amherst.
"The Pharmacotherapy of Respiratory Diseases Symposium," which targets pharmacists in all practice settings, has been developed by the University at Buffalo Department of Pharmacy Practice and the UB School of Medicine and Biomedical Sciences, with support from Merck, Inc.
The program also will illustrate the academic and clinical relationships that have grown within the Western New York community of physicians and pharmacy practitioners.
It will include a discussion of the pathophysiology of respiratory diseases, provide an update on the pathogenesis of asthma, describe the innovative roles for pharmacists in the management of respiratory disease, review the pharmacology of drugs used for smoking cessation and discuss patient-education and behavioral-modification issues that relate to smoking cessation.
Attendees can earn up to 12 contact hours of live continuing-education credit.
To register, call (716) 645-2886, ext. 247.